Brief: Xilio Therapeutics Transfers Listing Of Co's Common Stock To Nasdaq Capital Market
03/10/2025 13:03
Oct 3 (Reuters) - SEC Filing: XILIO THERAPEUTICS - TRANSFERS LISTING OF CO'S COMMON STOCK TO NASDAQ CAPITAL MARKET,EFFECTIVE OCTOBER 6 - SEC FILING Source text: [ID:n0001193125-25-229231] Further company coverage: XLO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla